The CAB will lead and advise Genprex as it advances its REQORSA immunogen therapy program, including its Acclaim clinical trials in non-small cell lung...
New Jersey, United States, - The latest research report added to Intellect Repository of market research is an in-depth analysis of the worldwide Animal...